Genome-wide association studies (GWAS) with case-control design have shown that another SCN5A-mediated condition, Brugada syndrome, is more likely to develop in patients who carry multiple common variants with a small effect, referred to as small nucleotide polymorphisms (SNPs). Here, SCN5A is linked to Brugada syndrome.